Natalie A. Prow

3.6k total citations
73 papers, 2.6k citations indexed

About

Natalie A. Prow is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Insect Science. According to data from OpenAlex, Natalie A. Prow has authored 73 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Public Health, Environmental and Occupational Health, 60 papers in Infectious Diseases and 13 papers in Insect Science. Recurrent topics in Natalie A. Prow's work include Mosquito-borne diseases and control (64 papers), Viral Infections and Vectors (54 papers) and Malaria Research and Control (16 papers). Natalie A. Prow is often cited by papers focused on Mosquito-borne diseases and control (64 papers), Viral Infections and Vectors (54 papers) and Malaria Research and Control (16 papers). Natalie A. Prow collaborates with scholars based in Australia, United States and Japan. Natalie A. Prow's co-authors include Roy A. Hall, David N. Irani, Alexander A. Khromykh, Andreas Suhrbier, Jody Hobson‐Peters, Helle Bielefeldt‐Ohmann, Yin Xiang Setoh, Willy W. Suen, Joy Gardner and Judith H. Edmonds and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

In The Last Decade

Natalie A. Prow

73 papers receiving 2.6k citations

Peers

Countries citing papers authored by Natalie A. Prow

Since Specialization

Citations

This map shows the geographic impact of Natalie A. Prow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalie A. Prow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalie A. Prow more than expected).

Fields of papers citing papers by Natalie A. Prow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalie A. Prow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalie A. Prow. The network helps show where Natalie A. Prow may publish in the future.

Co-authorship network of co-authors of Natalie A. Prow

This figure shows the co-authorship network connecting the top 25 collaborators of Natalie A. Prow. A scholar is included among the top collaborators of Natalie A. Prow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalie A. Prow. Natalie A. Prow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The vaccinia‐based Sementis Copenhagen Vector coronavirus disease 2019 vaccine induces broad and durable cellular and humoral immune responses 2022 ·Immunology and Cell Biology ·Preethi Eldi, (unknown), Natalie A. Prow, Liang Liu, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Kerrilyn R. Diener, John D. Hayball	4
2	Injection site vaccinology of a recombinant vaccinia-based vector reveals diverse innate immune signatures 2021 ·PLoS Pathogens ·(unknown), Troy Dumenil, Thuy T. Le, Andrii Slonchak, Stephen H. Kazakoff, Ann‐Marie Patch, (unknown), Paul M. Howley, Liang Liu, John D. Hayball, Kexin Yan, Daniel J. Rawle, Natalie A. Prow, Andreas Suhrbier	14
3	Granzyme A in Chikungunya and Other Arboviral Infections 2020 ·Frontiers in Immunology ·Alessandra Soares‐Schanoski, Thuy T. Le, Dion Kaiserman, Caitlin L. Rowe, Natalie A. Prow, (unknown), Cliomar Alves dos Santos, Paolo M. A. Zanotto, Kelly Grace Magalhães, Luigi Aurelio, David A. Muller, Paul R. Young, Peishen Zhao, Phillip I. Bird, Andreas Suhrbier	30
4	The vaccinia virus based Sementis Copenhagen Vector vaccine against Zika and chikungunya is immunogenic in non-human primates 2020 ·npj Vaccines ·Natalie A. Prow, Liang Liu, Mary K. McCarthy, Kevin Walters, Raj Kalkeri, (unknown), Fusataka Koide, (unknown), Preethi Eldi, Eri Nakayama, Kerrilyn R. Diener, Paul M. Howley, John D. Hayball, Thomas E. Morrison, Andreas Suhrbier	17
5	NS1 DNA vaccination protects against Zika infection through T cell–mediated immunity in immunocompetent mice 2019 ·Science Advances ·Branka Grubor‐Bauk, Danushka K. Wijesundara, Makutiro G. Masavuli, Peter Abbink, Rebecca Peterson, Natalie A. Prow, Rafael A. Larocca, Zelalem A. Mekonnen, Ashish C. Shrestha, Nicholas S. Eyre, Michael R. Beard, Jason Gummow, Jillian M. Carr, Sarah A. Robertson, John D. Hayball, Dan H. Barouch, Eric J. Gowans	61
6	A vaccinia-based single vector construct multi-pathogen vaccine protects against both Zika and chikungunya viruses 2018 ·Nature Communications ·Natalie A. Prow, Liang Liu, Eri Nakayama, (unknown), Kexin Yan, Preethi Eldi, (unknown), Bing Tang, Thuy T. Le, Yin Xiang Setoh, Alexander A. Khromykh, Jody Hobson‐Peters, Kerrilyn R. Diener, Paul M. Howley, John D. Hayball, Andreas Suhrbier	64
7	Differential Diagnosis of Flavivirus Infections in Horses Using Viral Envelope Protein Domain III Antigens in Enzyme-Linked Immunosorbent Assay 2017 ·Vector-Borne and Zoonotic Diseases ·Thisun B. H. Piyasena, Yin Xiang Setoh, Jody Hobson‐Peters, Natalie A. Prow, Helle Bielefeldt‐Ohmann, Alexander A. Khromykh, David Perera, Mary Jane Cardosa, Peter D. Kirkland, Roy A. Hall	6
8	Production of a Chikungunya Vaccine Using a CHO Cell and Attenuated Viral-Based Platform Technology 2017 ·Molecular Therapy ·Preethi Eldi, (unknown), Liang Liu, Natalie A. Prow, Kerrilyn R. Diener, Paul M. Howley, Andreas Suhrbier, John D. Hayball	17
9	Inactivation of dengue, chikungunya, and Ross River viruses in platelet concentrates after treatment with ultraviolet C light 2016 ·Transfusion ·Helen M. Faddy, (unknown), Natalie A. Prow, Daniel Watterson, Paul R. Young, Roy A. Hall, Frank Tolksdorf, Chryslain Sumian, Ute Gravemann, Axel Seltsam, Denese C. Marks	35
10	Tissue-specific transcription profile of cytokine and chemokine genes associated with flavivirus control and non-lethal neuropathogenesis in rabbits 2016 ·Virology ·Willy W. Suen, Muhammad Jasim Uddin, Natalie A. Prow, Richard A. Bowen, Roy A. Hall, Helle Bielefeldt‐Ohmann	9
11	Chikungunya virus transmission between Aedes albopictus and laboratory mice 2016 ·Parasites & Vectors ·Leon E. Hugo, Natalie A. Prow, Bing Tang, Gregor J. Devine, Andreas Suhrbier	21
12	Effective cutaneous vaccination using an inactivated chikungunya virus vaccine delivered by Foroderm 2015 ·Vaccine ·Penny A. Rudd, Anthony P. Raphael, Miko Yamada, (unknown), Joy Gardner, Thuy T. Le, Natalie A. Prow, Nhung Dang, Wayne A. Schroder, Tarl W. Prow, Andreas Suhrbier	10
13	Viral RNA Intermediates as Targets for Detection and Discovery of Novel and Emerging Mosquito-Borne Viruses 2015 ·PLoS neglected tropical diseases ·Caitlin A. O’Brien, Jody Hobson‐Peters, Alice Wei Yee Yam, Agathe M. G. Colmant, Breeanna J. McLean, Natalie A. Prow, Daniel Watterson, Sonja Hall‐Mendelin, David Warrilow, Mah Lee Ng, Alexander A. Khromykh, Roy A. Hall	90
14	A sensitive epitope-blocking ELISA for the detection of Chikungunya virus-specific antibodies in patients 2015 ·Journal of Virological Methods ·Lucas Y. H. Goh, Yiu‐Wing Kam, Stefan Metz, Jody Hobson‐Peters, Natalie A. Prow, Suzi McCarthy, David W. Smith, Gorben P. Pijlman, Lisa F. P. Ng, Roy A. Hall	7
15	Infectious Chikungunya Virus in the Saliva of Mice, Monkeys and Humans 2015 ·PLoS ONE ·Joy Gardner, Penny A. Rudd, Natalie A. Prow, Essia Belarbi, Pierre Roques, Thibaut Larcher, Lionel Gresh, Ángel Balmaseda, Eva Harris, Wayne A. Schroder, Andreas Suhrbier	33
16	Role of enhanced vector transmission of a new West Nile virus strain in an outbreak of equine disease in Australia in 2011 2014 ·Parasites & Vectors ·Andrew F. van den Hurk, Sonja Hall‐Mendelin, Cameron Webb, Cindy S. E. Tan, Francesca D. Frentiu, Natalie A. Prow, Roy A. Hall	24
17	The Australian Public is Still Vulnerable to Emerging Virulent Strains of West Nile Virus 2014 ·Frontiers in Public Health ·Natalie A. Prow, (unknown), Helen M. Faddy, (unknown), Wenqi Wang, Tarnya Cox, Roy A. Hall, Helle Bielefeldt‐Ohmann	17
18	A New Insect-Specific Flavivirus from Northern Australia Suppresses Replication of West Nile Virus and Murray Valley Encephalitis Virus in Co-infected Mosquito Cells 2013 ·PLoS ONE ·Jody Hobson‐Peters, Alice Wei Yee Yam, Jennifer Lu, Yin Xiang Setoh, Fiona J. May, Nina Kurucz, Susan Walsh, Natalie A. Prow, Steven Davis, Richard Weir, Lorna Melville, (unknown), Richard I. Webb, Bradley J. Blitvich, Peter I Whelan, Roy A. Hall	188
19	Nanopatch‐Targeted Skin Vaccination against West Nile Virus and Chikungunya Virus in Mice 2010 ·Small ·Tarl W. Prow, Xianfeng Chen, Natalie A. Prow, Germain J. P. Fernando, Cindy S. E. Tan, Anthony P. Raphael, David Chang, Merja Ruutu, Derek W. K. Jenkins, Alyssa T. Pyke, Michael L. Crichton, (unknown), Lucas Y. H. Goh, Ian H. Frazer, Michael S. Roberts, Joy Gardner, Alexander A. Khromykh, Andreas Suhrbier, Roy A. Hall, M. A. F. Kendall	133
20	Arboviruses Isolated from Mosquitoes Collected from Urban and Peri-urban Areas of Eastern Australia 2009 ·Journal of the American Mosquito Control Association ·Cassie C. Jansen, Natalie A. Prow, Cameron Webb, Roy A. Hall, Alyssa T. Pyke, Bruce Harrower, (unknown), Paul Zborowski, Scott A. Ritchie, Richard C. Russell, Andrew F. van den Hurk	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact